The most common subtype of lung cancer is non-small cell lung cancer (NSCLC), which has a poor prognosis and seriously threatens the health of human beings. The multidisciplinary comprehensive treatment model has gradually become the mainstream of NSCLC treatment. Traditional Chinese medicine (TCM) can be used effectively either as an adjunctive therapy or alone throughout the NSCLC therapy, which has a significant impact on survival, quality of life, and reduction of toxicity. Therefore, this paper reviewed the theoretical basis, the latest clinical application, and combined treatment mechanisms in order to explore the advantage stage of TCM treatment and the synergistic therapeutic mechanisms.
This work was supported by National Administration of Traditional Chinese Medicine: The Seventh Batch of National Traditional Chinese Medicine Experts Academic Experience Inheritance Project; Tianjin Municipal Education Commission Scientific Research Plan Project (No. 2021KJ143).
Fanming Kong a, b,, Chaoran Wang a, b,c,, Linlin Zhao a, b, Dongying Liao a, b,c, Xiaoqun Wang a, b, Binxu Sun a, b, Peiying Yang a, b, Yingjie Jia a, b,*. Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms[J]. Chinese Herbal Medicines (CHM),2023,15(4):509-515
Share
Article Metrics
Abstract views:
PDF downloads:
Html views:
Cited by:
History
Manuscript received:
Manuscript revised:
Adopted:
Online Published: November 09,2023
Published:
WeChat
Mobile website
Chinese Herbal Medicines (CHM) ® 2025 All Rights Reserved 津備案:津ICP備13000267號
互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號:(津)-非經(jīng)營性-2015-0031